Director, Value & Evidence – Hospital Pipeline

The Director, Value & Evidence – Hospital Pipeline will support the strategic goals of the Hospital Value & Access team by driving optimal patient access for Hospital products and Anti-infective treatment.

This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access by demonstrating the value of medicines in the hospital portfolio. The Value & Evidence Director will be responsible for developing and executing against the global evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables.

This position will function with a ‘One Patient & Health Impact’ mindset and will work in a closely aligned fashion with the Hospital Patient & Health Impact (PHI) team members to ensure there is a single and coordinated view on strategy and delivery from the PHI team to the broader Hospital BU.

ROLE RESPONSIBILITIES

• Execute projects as part of the Value & Access team working on the evidence generation strategy to support the value of hospital pipeline assets and other hospital assets as assigned in close partnership with the cross-functional matrix team.
• Incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements. Provide strategic input into clinical trial designs (eg, patient populations, comparators, endpoints) to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
• Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the evidence strategy to support global market access needs at launch and through lifecycle.
• Lead the design and execution of global Value & Evidence and health economics & outcomes research (HEOR) projects (eg, economic models, network meta-analyses, non-interventional studies) from concept through publication.
• Lead the timely development of launch deliverables including early global value dossiers, evidence blueprints, systematic literature reviews, early economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries.
• Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs.
• Develop and validate new patient-reported outcome measures (as appropriate) for inclusion across clinical trials, registries, and prospective studies.
• Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community settings to support asset strategies.

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop, and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• Graduate degree (e.g. MSc, MPH, PhD) and 7+ years of experience in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field) or equivalent experience
• Demonstrated in depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies including technical and methodological aspects of registries and observational study design, implementation, analysis and interpretation. Capable of independently managing complex non-interventional study projects.
• Knowledge and understanding of drug development process is strongly preferred
• Experience providing pipeline HEOR support (eg, prior close collaboration with clinical, product development, and regulatory teams) is strongly preferred
• Knowledge and experience in the therapeutic area is preferred.
• Experience with HTA organizations such as NICE, CADTH, PBAC, ICER and other HTA groups is desirable
• Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
• Excellent oral and written English communication skills required
• Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
• An “execution mindset” focused on getting things done quickly and simply
• Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
• Ability to influence key members of medical, clinical, and commercial teams constructively and without conflict
• Skilled in functioning within a matrix organization; managing through influence is required
• Organized and detail oriented with the ability to anticipate needs and to work proactively to prioritize & address/resolve
• Change oriented, comfortable responding to unexpected demands with tight timelines; team player

NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS

• Ability to travel domestically and internationally

Other Job Details:

• Last Date to Apply for Job ​: 09/29/2022
• Eligible for employee referral bonus

Relocation assistance may be available based on business needs and/or eligibility.

Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.